Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | sodium coupled monocarboxylate transporter 1 | 0.026 | 0.2365 | 0.2347 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0355 | 0.1501 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0163 | 0.0163 |
Brugia malayi | GH02984p | 0.026 | 0.2365 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0186 | 0.0163 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.0609 | 0.2573 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0215 | 0.0703 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0215 | 0.0911 |
Echinococcus multilocularis | sodium:glucose cotransporter 2 | 0.1019 | 1 | 1 |
Schistosoma mansoni | high-affinity choline transporter | 0.026 | 0.2365 | 0.2365 |
Echinococcus multilocularis | high affinity choline transporter 1 | 0.026 | 0.2365 | 0.2347 |
Schistosoma mansoni | sodium/solute symporter | 0.026 | 0.2365 | 0.2365 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0138 | 0.1133 | 0.479 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0138 | 0.1133 | 0.1112 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1808 | 0.1789 |
Schistosoma mansoni | inositol transporter | 0.1019 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.1133 | 0.1133 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0355 | 0.131 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0163 | 0.0482 |
Echinococcus multilocularis | sodium:myo inositol cotransporter | 0.1019 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0138 | 0.1133 | 0.1112 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0355 | 0.131 |
Echinococcus granulosus | sodium:glucose cotransporter 2 | 0.1019 | 1 | 1 |
Echinococcus multilocularis | solute carrier family 5 | 0.1019 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0475 | 0.0452 |
Echinococcus multilocularis | sodium coupled monocarboxylate transporter 1 | 0.026 | 0.2365 | 0.2347 |
Onchocerca volvulus | 0.026 | 0.2365 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0244 | 0.1033 |
Toxoplasma gondii | transporter, solute:sodium symporter (SSS) family protein | 0.026 | 0.2365 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1808 | 0.1808 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.1133 | 0.1133 |
Echinococcus granulosus | geminin | 0.0205 | 0.1808 | 0.1789 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0186 | 0.0163 |
Echinococcus granulosus | high affinity choline transporter 1 | 0.026 | 0.2365 | 0.2347 |
Brugia malayi | Sodium:solute symporter family protein | 0.026 | 0.2365 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0163 | 0.0691 |
Loa Loa (eye worm) | hypothetical protein | 0.026 | 0.2365 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0138 | 0.1133 | 0.4673 |
Echinococcus granulosus | sodium:myo inositol cotransporter | 0.1019 | 1 | 1 |
Schistosoma mansoni | inositol transporter | 0.1019 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1808 | 0.1808 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0475 | 0.0452 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0138 | 0.1133 | 0.1112 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0023 | 0.0023 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.0518 | 0.0518 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.0661 | 0.2631 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0267 | 0.1131 |
Loa Loa (eye worm) | hypothetical protein | 0.026 | 0.2365 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.1133 | 0.1133 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0355 | 0.1501 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0138 | 0.1133 | 0.1112 |
Echinococcus granulosus | solute carrier family 5 | 0.1019 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 4.6109 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 112.2018 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.